Please assess the completion status of the following clinical trial:

Trial Title: Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be at least 18 years of age and younger than 90 years of age~* Diagnosed with calcific tendonitis and ruled out other shoulder-related pathologies~* Failed 1st line therapy (physical therapy and cortisone injection)~  * Intention to receive barbotage with cortisone as standard of care~ * 3 or more months of shoulder pain~ * Finding of one or more calcifications ≥5 mm in size on either sonogram or radiograph, located on the supraspinatus tendon~ * Positive Hawkin's test or Neer's sign for impingement~Exclusion Criteria:~* Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)~* Osteoarthritis of the glenohumeral joint of the affected shoulder~* Previous surgery or barbotage to the affected shoulder~* History of prior allergic/hypersensitivity reactions related to the study medication~* Shoulder instability, glenohumeral arthritis, AC pathology, inflammatory arthropathy, fibromyalgia, frozen shoulder or cervical radiculopathy~* Sub-acromial injection with a corticosteroid or treatment by ESWT during the last 3 months before inclusion~* Younger than 18 years of age or older than 90~* Any patient considered a vulnerable subject

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Barbotage Injection (Type: EXPERIMENTAL): Subjects receiving barbotage with saline injection
- Barbotage with Cortisone Injection (Type: ACTIVE_COMPARATOR): Subjects receiving barbotage with cortisone injection

Based on this trial design, predict the completion outcome and termination type (if applicable).